课题基金 / 基金详情

TARGET CELL SPECIFIC GENE TRANSFER BY ANTIFECTION AND REGULATION OF PROLIFERATION OF CANCER CELLS

TARGET CELL SPECIFIC GENE TRANSFER BY ANTIFECTION AND REGULATION OF PROLIFERATION OF CANCER CELLS
通过抑制和调节癌细胞增殖进行靶细胞特异性基因转移
批准号:
10470173
负责人:
TSUCHIYA Shigeru
金额:
$7.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

TSUCHIYA Shigeru的其他基金

相似基金

相关文献

中文摘要
翻译
目的:为了开发一种抗体介导的靶向基因转染新技术--抗感染方法,我们确定了基因转移的最佳条件。材料与方法:用苯醌将抗CD 3抗体OKT 3化学偶联到含有绿色荧光蛋白(GFP)基因的质粒DNA上。通过将混合物在40%蔗糖溶液上分层,然后进行超离心来富集Ab-DNA缀合物。DNA和Ab之间的偶联通过1%琼脂糖凝胶电泳,然后通过抗小鼠IgG抗体进行蛋白质印迹来确定。结果与讨论:琼脂糖凝胶电泳显示,与单独的质粒DNA相比,Ab-DNA偶联物的电泳迁移率发生了变化。Western印迹显示抗小鼠IgG抗体与Ab-DNA反应混合物中观察到的条带反应,表明Ab-DNA缀合物的存在。通过将脂质(FuGENE)偶联到Ab-DNA缀合物上,观察到Ab-DNA缀合物成功转染到Jurkat细胞中。氯喹由于其细胞毒性而未能赋予成功的转染。抗转染可能是基因治疗的一种有效方法。
英文摘要
Purpose : To develop an antifection method, a new technique of antibody-mediated targeted gene transfection, we determined optimal conditions of the gene transfer.Materials and Methods : OKT3, the antibody (Ab) against CD3 was chemically conjugated using benzoquinone to pEGFP, plasmid DNA containing green fluorescent protein (GFP) gene. The Ab-DNA conjugate was enriched by layering the mixture on a 40% sucrose solution followed by an ultracentrifugation. Coupling between DNA and Ab was determined by a 1% agarose gel electrophoresis followed by western blotting by anti-mouse IgG antibody. Jurkat T cells expressing CD3 were incubated with the Ab-DNA conjugate, and then determined the expression of GFP by flowcytometry.Results and Discussion : Agarose gel electrophoresis showed a change of the electrophoretic mobility in the Ab-DNA conjugate, as compared to plasmid DNA alone. The western blot revealed that anti-mouse IgG antibody reacted against the observed band in the Ab-DNA reaction mixture, indicating the existence of the Ab-DNA conjugate. Successful transfection of the Ab-DNA conjugate into Jurkat cells was observed by coupling lipids (FuGENE) to the Ab-DNA conjugate. Chloroquine failed to confer successful transfection due to its cytotoxicity. Antifection could be an useful method for gene therapy.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kumaki S, Ishii N, Minegishi M, Tsuchiya S, Cosman D, Sugamura K and Konno T: "Functional role of interleukin-4(IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency"Blood. 93. 607-612 (1999)
Kumaki S、Ishii N、Minegishi M、Tsuchiya S、Cosman D、Sugamura K 和 Konno T:“白细胞介素 4 (IL-4) 和 IL-7 在 X 连锁严重联合免疫缺陷发展中的功能作用”血液。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kumaki S et al.: "Prolonged secretion of IL-15 in patients with severe forms of graft-versus-host disease after allogeneic bone marrow transplantation in children" International J Hematology. 67. 307-312 (1998)
Kumaki S 等人:“儿童同种异体骨髓移植后患有严重移植物抗宿主病的患者 IL-15 分泌延长”《国际血液学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kawai S, Sasahara Y, Minegishi M, Tsuchiya S, Fujie H, Ohashi Y, Kumaki S, Konno T: "Immunological reconstitution by allogeneic bone marrow transplantation in a child with the X-linked hyper-IgM syndrome"Eur J Pediatr. 158. 394-397 (1999)
Kawai S、Sasahara Y、Minegishi M、Tsuchiya S、Fujie H、Ohashi Y、Kumaki S、Konno T:“X 连锁高 IgM 综合征儿童通过同种异体骨髓移植进行免疫重建”Eur J Pediatr。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
28
    Homologous recombination-mediated gene correction in iPS cells o Ornithine transcarbamylase deficiency
    • 批准号:
      23659511
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      TSUCHIYA Shigeru
    • 依托单位:
    Leukemogenesis due to insertional mutagenesis-a NOG mouse model-
    • 批准号:
      19390280
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2007
    • 负责人:
      TSUCHIYA Shigeru
    • 依托单位:
    Induction of human cytotoxic T cells by peptide-pulsed universal antigen presenting cells
    • 批准号:
      16390294
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2004
    • 负责人:
      TSUCHIYA Shigeru
    • 依托单位:
    GENE THERAPY FOR X-LINKED SEVERE COMBINED IMMUNODEFICIENCY DISEASE
    • 批准号:
      14370240
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      2002
    • 负责人:
      TSUCHIYA Shigeru
    • 依托单位:
    海外基金